Research programme: growth arrest specific gene 6 inhibitors - ThromboGenics

Drug Profile

Research programme: growth arrest specific gene 6 inhibitors - ThromboGenics

Alternative Names: Gas6 inhibitors research programme - ThromboGenics; Growth arrest specific gene 6 inhibitors research programme - ThromboGenics

Latest Information Update: 04 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Leuven
  • Developer Thromb-X; ThromboGenics
  • Class
  • Mechanism of Action Growth arrest-specific protein 6 inhibitors; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Thrombosis

Most Recent Events

  • 04 Jun 2003 This programme is still in active development
  • 22 May 2001 New profile
  • 22 May 2001 Preclinical development for Arterial thrombosis in Europe (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top